These observations add to the emerging evidence that plasma fibulin-1 levels are reflective of cardiovascular disease, including findings showing that plasma fibulin-1 levels are associated with LA size and blood levels of NT-proBNP5 in patients with diabetes mellitus. Here, FBLN1 is linked to diabetes mellitus.